AI
OFIX icon

Atom Investors’s Orthofix Medical OFIX Stock Holding History

Atom Investors’s Portfolio OFIX Stock Details OFIX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-21,784
Closed -$319K – 744
2025
Q3 		$319K Sell
21,784
-15,191
-41% -$199K 0.02% 434
2025
Q2 		$412K Buy
+36,975
New +$458K 0.04% 384

Other funds holding OFIX

ECM
Engine Capital Management New York $828M AUM 6.49% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return
JIC
Juniper Investment Company New York $313M AUM 79.58% 1-Year Est. Return
PCMI
Paradigm Capital Management Inc Albany, New York $2.61B AUM 78.58% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
PCM
Philosophy Capital Management Alamo, California $1.63B AUM 12.69% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Atom Investors's OFIX Position: Q4 2025 in Review

Atom Investors sold out of Orthofix Medical (OFIX) in Q4 2025, closing a stake of 21,784 shares — an estimated $319K sold.

Atom Investors first reported a position in OFIX in Q2 2025 and held it in 2 quarters. The position peaked at $412K in Q2 2025. 143 funds tracked by Wall St. Rank hold OFIX as of Q4 2025.

  • Atom Investors reported no remaining Orthofix Medical position as of Q4 2025 after selling out during the quarter.
  • Atom Investors sold 21,784 Orthofix Medical shares in Q4 2025, an estimated $319K.
  • Atom Investors first reported a position in Orthofix Medical in Q2 2025 and held it in 2 quarters.
  • Atom Investors's Orthofix Medical position peaked at $412K in Q2 2025.
  • 143 funds tracked by Wall St. Rank held Orthofix Medical as of Q4 2025.

Based on Atom Investors's 13F filing for Q4 2025, filed 17 Feb 2026.